AU782623B2 - Oligosaccharide mixture - Google Patents

Oligosaccharide mixture Download PDF

Info

Publication number
AU782623B2
AU782623B2 AU20062/01A AU2006201A AU782623B2 AU 782623 B2 AU782623 B2 AU 782623B2 AU 20062/01 A AU20062/01 A AU 20062/01A AU 2006201 A AU2006201 A AU 2006201A AU 782623 B2 AU782623 B2 AU 782623B2
Authority
AU
Australia
Prior art keywords
oligosaccharides
oligosaccharide
animal
oligosaccharide mixture
milk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU20062/01A
Other languages
English (en)
Other versions
AU2006201A (en
Inventor
Gunther Bohm
Berndt Finke
Gilda Georgi
Jurgen Jelinek
Joachim J. Schmitt
Bernd Stahl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutricia NV
Original Assignee
Nutricia NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7931729&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU782623(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia NV filed Critical Nutricia NV
Publication of AU2006201A publication Critical patent/AU2006201A/en
Application granted granted Critical
Publication of AU782623B2 publication Critical patent/AU782623B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Fodder In General (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Materials For Medical Uses (AREA)
AU20062/01A 1999-12-07 2000-12-07 Oligosaccharide mixture Ceased AU782623B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19958985 1999-12-07
DE19958985A DE19958985A1 (de) 1999-12-07 1999-12-07 Oligosaccharidmischung
PCT/EP2000/012345 WO2001042263A2 (de) 1999-12-07 2000-12-07 Oligosaccharidmischung

Publications (2)

Publication Number Publication Date
AU2006201A AU2006201A (en) 2001-06-18
AU782623B2 true AU782623B2 (en) 2005-08-18

Family

ID=7931729

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20062/01A Ceased AU782623B2 (en) 1999-12-07 2000-12-07 Oligosaccharide mixture

Country Status (20)

Country Link
US (1) US7939118B2 (cs)
EP (1) EP1242436B1 (cs)
JP (1) JP2003516412A (cs)
CN (1) CN1198624C (cs)
AT (1) ATE282626T1 (cs)
AU (1) AU782623B2 (cs)
BR (1) BR0016161A (cs)
CA (1) CA2394090C (cs)
CZ (1) CZ304817B6 (cs)
DE (2) DE19958985A1 (cs)
DK (1) DK1242436T3 (cs)
ES (1) ES2233485T3 (cs)
HK (1) HK1052438B (cs)
HU (1) HUP0203707A3 (cs)
MX (1) MXPA02005491A (cs)
NO (1) NO330050B1 (cs)
NZ (1) NZ519706A (cs)
PL (1) PL356238A1 (cs)
PT (1) PT1242436E (cs)
WO (1) WO2001042263A2 (cs)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1243273A1 (en) * 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
NZ515869A (en) * 2001-11-30 2003-09-26 Med Chem Ingredients Ltd Compositions and methods for animal treatment comprising gluco- and isomalto- oligosaccharides
AU2005274824A1 (en) 2004-07-19 2006-02-23 Life Science Nutrition As NGNA compositions and methods of use
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
EP1634599A1 (en) 2004-08-20 2006-03-15 N.V. Nutricia Iimmune stimulatory infant nutrition
CN101123888B (zh) * 2005-02-21 2016-03-23 雀巢技术公司 寡糖混合物
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8287931B2 (en) * 2005-06-30 2012-10-16 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
DE602007006635D1 (en) 2006-02-10 2010-07-01 Nestec Sa Oligosaccharidmischung
PL1993576T3 (pl) * 2006-03-07 2016-04-29 Nestec Sa Mieszanina synbiotyczna
WO2007114683A1 (en) 2006-03-30 2007-10-11 N.V. Nutricia Milk oligosaccharides for stimulating the immune system
EP1974743A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
US20100196539A1 (en) * 2007-06-25 2010-08-05 Albertus Alard Van Dijk Novel prebiotics
AU2008324105B2 (en) * 2007-11-08 2014-01-30 Société des Produits Nestlé S.A. Use of oligosaccharides containing N-acetyllactosamine for maturation of immune responses in neonates
EP2143341A1 (en) * 2008-07-08 2010-01-13 Nestec S.A. Nutritional Composition Containing Oligosaccharide Mixture
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
US20100119558A1 (en) 2008-11-10 2010-05-13 Scandivir Ab Ngna compositions and methods of use
JP2012510476A (ja) * 2008-12-02 2012-05-10 プロラクタ バイオサイエンス，インコーポレイテッド ヒト乳透過組成物ならびにその製造および使用方法
US8425955B2 (en) * 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
US8785160B2 (en) 2009-02-24 2014-07-22 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
SG10201901259RA (en) 2009-02-24 2019-03-28 Ritter Pharmaceuticals Inc Prebiotic formulations and methods of use
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
AU2015306339A1 (en) 2014-08-18 2016-12-15 Société des Produits Nestlé S.A. Prebiotics for reducing the risk of obesity later in life
EP2455387A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
CN107019701B (zh) 2010-12-31 2020-07-28 雅培制药有限公司 使用人乳低聚糖来降低婴儿、幼儿或儿童的坏死性小肠结肠炎的发病率的方法
ES2804258T3 (es) 2010-12-31 2021-02-05 Abbott Lab Procedimientos para reducir la incidencia de estrés oxidativo usando oligosacáridos de leche humana, vitamina C y agentes antiinflamatorios
CA2822490C (en) 2010-12-31 2020-03-31 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
MY191538A (en) 2010-12-31 2022-06-30 Abbott Lab Human milk oligosaccharides to promote growth of beneficial bacteria
ES2667393T3 (es) 2010-12-31 2018-05-10 Abbott Laboratories Oligosacáridos de leche humana para modular inflamación
US8802650B2 (en) 2010-12-31 2014-08-12 Abbott Laboratories Methods of using human milk oligosaccharides for improving airway respiratory health
MY166945A (en) 2010-12-31 2018-07-25 Abbott Lab Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
EP2704597B1 (en) * 2011-05-05 2021-04-07 Life Science Nutrition AS Performance enhancing compositions and methods of use
EP2526784A1 (en) * 2011-05-24 2012-11-28 Nestec S.A. Milk oligosaccharide-galactooligosaccharide composition for infant formula containing the soluble oligosaccharide fraction present in milk, and having a low level of monosaccharides, and a process to produce the composition
CA2846603A1 (en) * 2011-08-29 2013-03-07 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
AU2014368585A1 (en) 2013-12-19 2016-05-19 Nestec S.A. Nutritional composition for use in reducing metabolic stress in infants, decreasing gut permeability and approximating growth rate of breast-fed infants
SG11201705549YA (en) * 2015-01-20 2017-08-30 Meiji Co Ltd Composition for suppressing phosphorus absorption
PL3277287T3 (pl) 2015-03-31 2024-04-22 Glycom A/S Mieszaniny oligosacharydów mleka ludzkiego zawierające 3'-O-sialilolaktozę
MX2022002949A (es) 2019-09-24 2022-04-06 Prolacta Bioscience Inc Composiciones y metodos para el tratamiento de enfermedades inflamatorias e inmunes.
US10933097B1 (en) 2020-03-05 2021-03-02 King Saud University Method of treating a bacterial infection using colostrum
CN118141112B (zh) * 2024-03-21 2026-03-06 澳优乳业（中国）有限公司 一种缓解肠道氧化应激损伤的组合物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1324529C (en) * 1987-09-15 1993-11-23 Tatsuhiko Kan Liquid food comprising polydextrose and oligosaccharides
JP2518663B2 (ja) * 1987-12-24 1996-07-24 株式会社ヤクルト本社 ガラクトオリゴ糖含有加工乳の製造法
JP3070890B2 (ja) * 1993-02-12 2000-07-31 オルガノ株式会社 澱粉糖の製造方法
US5750176A (en) * 1994-03-09 1998-05-12 Abbott Laboratories Transgenic non-human mammal milk comprising 2'-fucosyl-lactose
JP3789146B2 (ja) * 1995-03-27 2006-06-21 雪印乳業株式会社 オリゴ糖含有栄養組成物
DE19701382A1 (de) * 1997-01-16 1998-07-23 Nutricia Nv Kohlenhydratmischung
US6045854A (en) * 1997-03-31 2000-04-04 Abbott Laboraties Nutritional formulations containing oligosaccharides

Also Published As

Publication number Publication date
ES2233485T3 (es) 2005-06-16
AU2006201A (en) 2001-06-18
BR0016161A (pt) 2002-10-29
HK1052438A1 (en) 2003-09-19
EP1242436B1 (de) 2004-11-17
DE50008706D1 (en) 2004-12-23
HK1052438B (zh) 2005-07-08
CA2394090C (en) 2010-09-28
EP1242436A2 (de) 2002-09-25
PL356238A1 (pl) 2004-06-28
CN1407857A (zh) 2003-04-02
CZ20021876A3 (cs) 2003-05-14
WO2001042263A2 (de) 2001-06-14
HUP0203707A2 (hu) 2003-03-28
ATE282626T1 (de) 2004-12-15
CN1198624C (zh) 2005-04-27
NO20022688D0 (no) 2002-06-06
CZ304817B6 (cs) 2014-11-12
PT1242436E (pt) 2005-04-29
US7939118B2 (en) 2011-05-10
NZ519706A (en) 2004-03-26
MXPA02005491A (es) 2002-09-02
US20030129278A1 (en) 2003-07-10
DE19958985A1 (de) 2001-06-13
CA2394090A1 (en) 2001-06-14
WO2001042263A3 (de) 2001-11-01
NO20022688L (no) 2002-06-06
NO330050B1 (no) 2011-02-07
DK1242436T3 (da) 2005-03-14
HUP0203707A3 (en) 2004-12-28
JP2003516412A (ja) 2003-05-13

Similar Documents

Publication Publication Date Title
US7939118B2 (en) Oligosaccharide mixture
Brody Biological activities of bovine glycomacropeptide
Manso et al. κ-Casein macropeptides from cheese whey: Physicochemical, biological, nutritional, and technological features for possible uses
Martín et al. Distribution of bovine milk sialoglycoconjugates during lactation
CN100338085C (zh) 唾液酸化的碳水化合物
CA3080844A1 (en) A composition and uses thereof
AU2009218504B2 (en) Oligosaccharide ingredient
WO2019115769A1 (en) Separation of oligosaccharides from a dairy source
JP3789146B2 (ja) オリゴ糖含有栄養組成物
SK7812002A3 (en) Oligosaccharide mixture
AU2009341470B2 (en) Oligosaccharide ingredient
JP2001192393A (ja) 内在性シアリダーゼ耐性ラクトン体含有組成物

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 15, NO 44, PAGE(S) 9693-9696 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 75525/00, 75527/00 AND 20062/01

MK14 Patent ceased section 143(a) (annual fees not paid) or expired